The U.S. Food and Drug Administration (FDA) issued a complete response letter requesting additional information from ...

Congress has taken the final steps in the FY 2026 budget process, passing legislation that increases funding for lupus programs, including $27 million - the most in history - for lupus programs at the ...

Black History Month serves as a reminder to actively amplify Black voices, share stories and raise awareness throughout the year. This month, we’re featuring Danielle Storr, a Black lupus warrior who ...

The U.S. Food and Drug Administration (FDA) has granted Biogen’s investigational drug, litifilimab, Breakthrough Therapy Designation for the treatment of cutaneous lupus erythematosus (CLE).

In this episode of the Lupus Foundation of America's The Expert Series podcast, we focus on the newly released American College of Rheumatology treatment guidelines for systemic lupus erythematosus ...

The U.S. Food and Drug Administration (FDA) approved Gazyva® to treat adults with lupus nephritis in October 2025. Gazyva targets and removes harmful B cells to help protect the kidneys in people with ...

Learn more about how your company or organization can raise its profile and morale by becoming a corporate partner.

Our approach is innovative and removes barriers to progress. Watch this short video about three of our bold research initiatives to better understand lupus in children and teens, improve early ...

You can donate your car, truck, boat or RV to the Lupus Foundation of America and receive a tax deduction while supporting life-changing research. To learn more, fill out this form and a ...